Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dey L.P. to Market EMSAM Skin Patch for Treatment of Major Depressive Disorder
Mylan, 06/01/09

Dey L.P., a subsidiary of Mylan Inc. , announced that it has begun to market and distribute EMSAM in the U.S. EMSAM, a selegiline transdermal system, is a monoamine oxidase inhibitor, which was approved by the U.S. Food and Drug Administration in 2006 for the treatment of major depressive disorder.


Today in Marketing/Media/ROI...keeping you current

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

Shire Reports Tolerability and Clinical Effects Results of DAYTRANA from Study in Adolescents with ADHD
Shire, 11/02/09

See All of Marketing/Media/ROI

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address